Occupational therapist Elisa Castelao Alburquerque, from the breast cancer unit at the Instituto Oncológico (IOB, Madrid), explains how occupational therapy supports women with breast cancer as they return to everyday life: which effects it addresses, how it intervenes at each stage, and what the evidence says.
Overcoming breast cancer does not always mean returning to life as it was before: lymphedema, neuropathy, fatigue, and chemobrain can affect many women’s self-care, work, and roles for years.
In this article, you’ll learn what occupational therapy does in a breast cancer unit, how it evaluates and intervenes from diagnosis through survivorship, what clinical practice cases look like, and what the evidence says.
Occupational therapy in a breast cancer unit supports each woman from diagnosis through survivorship so she can maintain or regain independence in everyday life. Lymphedema, limited shoulder mobility, neuropathy, fatigue, or cancer-related cognitive impairment (chemobrain) can interfere with self-care, household tasks, caring for others, and work. Taking an occupation-centered approach, the occupational therapist evaluates these challenges and intervenes alongside the rest of the care team so the person can return to doing what she needs and values.
Introduction
Breast cancer is one of the most commonly diagnosed cancers in Spain: the Spanish Society of Medical Oncology estimates 38,318 new cases in 2026 (SEOM, 2026). Thanks to early detection and advances in treatment, most women overcome the disease. But overcoming cancer does not always mean returning to the life a person had before.
Surgery, chemotherapy, radiation therapy, and hormone therapy can leave physical, cognitive, and emotional effects that may last for years. These are often hard for others to see, yet they can completely change everyday life: getting dressed with limited shoulder function, forgetting a medical appointment, or being unable to get through a workday.
In this article, I explain what an occupational therapist does in a breast cancer unit, which effects they address, how they intervene at each stage of the cancer journey, and what the evidence says about their effectiveness.
What is a breast cancer unit, and what role does occupational therapy play?
A breast cancer unit brings together the professionals who care for women with breast cancer in one coordinated care pathway: medical and radiation oncology, surgery, nursing, physical therapy, psycho-oncology, nutrition, and other specialties. The goal is to provide comprehensive, coordinated care at every stage of the disease.
Within this team, occupational therapy brings a distinct perspective. While other disciplines focus on the tumor, treatment, or a specific function, the occupational therapist asks what the person can no longer do and what she needs to regain that ability. Its focus is on occupations: self-care, household tasks, work, caring for others, leisure, and social participation.
The American Occupational Therapy Association’s practice guidelines position OT across the full cancer care continuum and support its role in addressing fatigue, pain, sleep, cognition, psychosocial well-being, and physical activity (Newman et al., 2024). Even so, occupational therapists remain underrepresented in oncology units in Spain.
How patients are referred to occupational therapy
To make sure OT is not introduced too late, our unit uses a referral protocol that starts at diagnosis. Medical oncology, surgery, psycho-oncology, or the patient herself may make a referral when any of the following arise:
- Fatigue that affects daily life or work.
- Tingling, loss of sensation, or clumsiness in the hands or feet.
- Scar discomfort, shoulder stiffness, or difficulty using the arm on the side of surgery.
- Memory and concentration difficulties.
- Questions about returning to work, caregiving, or hobbies.
- Upcoming surgery, to allow for a preoperative evaluation.
During the first session, we assess occupational performance using the Canadian Occupational Performance Measure (COPM) and agree on two or three goals with the patient. Intervention is brief and individualized, progress is reassessed with the COPM, and a functional summary is shared with the oncologist. If warning signs arise or emotional distress is the primary concern, we refer the patient back to oncology or to psycho-oncology.

Subscribe
to our
Newsletter
Effects of breast cancer addressed by occupational therapy
The effects of breast cancer rarely occur in isolation. It is the combined impact of several of them that affects occupational performance:
- Scars and adaptation after surgery. Adherent or painful scars, excess tissue, and an ill-fitting bra or external prosthesis can affect dressing, body image, and social participation.
- Lymphedema and upper-extremity limitations. More than one in five survivors will develop arm lymphedema, with incidence increasing during the first two years after surgery (DiSipio et al., 2013).
- Peripheral neuropathy. Taxanes and platinum-based drugs are among the most neurotoxic chemotherapy agents (Zajączkowska et al., 2019). Neuropathy affects nearly 68% of patients in the first month after chemotherapy and persists in around 30% at six months or longer (Seretny et al., 2014).
- Cancer-related fatigue. Along with cognitive problems, it is the main reason survivors give for not returning to work or returning with reduced hours (Schmidt et al., 2019).
- Cancer-related cognitive impairment (chemobrain). It affects memory, attention, processing speed, and executive function, and has multiple contributing causes (Janelsins et al., 2014). Around one in three survivors may experience clinically significant impairment (Whittaker et al., 2022).
- Emotional impact. Fear of recurrence, changes in body image, and loss of roles.
| Effect | Impact on everyday life |
|---|---|
| Scar and prosthetic adaptation | Getting dressed, choosing clothes, body image, social life |
| Lymphedema and limited shoulder mobility | Personal hygiene, lifting and carrying, reaching overhead, holding a child |
| Peripheral neuropathy | Buttoning clothes, handling small objects, walking safely; risk of falls and burns |
| Cancer-related fatigue | Keeping up with work hours, household tasks, leisure, and social life |
| Cognitive impairment | Planning, managing appointments and medications, remembering conversations, performing at work |
How chemobrain is identified
Identifying chemobrain is not straightforward. In practice, the patient’s own perception is combined with questionnaires such as the FACT-Cog and neuropsychological and screening tests, although there is no consensus on which tools are best (Chiaravalloti et al., 2023). In addition, brief tests may not detect complaints that do interfere with everyday life.
Research is exploring more objective markers:
- Functional neuroimaging with PET or SPECT can show, for example, reduced cerebral glucose metabolism after chemotherapy (Chiaravalloti et al., 2023).
- In blood, researchers are studying neurofilament light chain (NfL), a marker of axonal damage. However, in a study of patients treated with paclitaxel, it was not useful for identifying cognitive impairment (Argyriou et al., 2022).
For now, these are research tools, so functional assessment remains essential: what matters most to the patient is how these difficulties affect her everyday life.
How occupational therapy intervenes throughout the cancer journey
Intervention is tailored to each stage of the disease. Bringing OT into care from the time of diagnosis, rather than waiting until the effects are established, allows for prevention, early identification, and ongoing support.
After diagnosis and before surgery
- Initial evaluation: occupational profile, upper-extremity function, fatigue, sleep, and cognition.
- Preventive education: possible treatment effects, warning signs of lymphedema, and planning routines for the months of treatment.
During treatment
- Functional recovery of the arm and scar care, integrated into real-life tasks.
- Fatigue management: energy conservation, prioritization, and adapted physical activity.
- Neuropathy: assistive products, adaptations to support dexterity, and fall prevention.
- Screening for cognitive concerns, including actively asking about forgetfulness or lapses in attention.
After treatment and during survivorship
- Cognitive rehabilitation: psychoeducation, compensatory strategies (planners, alarms, routines), and cognitive training linked to real-life goals.
- Return to work: job analysis, accommodations, and a gradual return.
- Rebuilding routines and roles: resuming meaningful activities.
Clinical practice cases
These anonymized cases show how the effects of cancer translate into everyday problems that often go unaddressed:
| Situation | What occupational therapy does |
|---|---|
| Woman after mastectomy with a scar featuring “dog ears” who wears an underwire bra and uses cotton pads instead of a prosthesis | Evaluates the scar, advises on a postmastectomy bra and appropriate external prosthesis, and informs the surgical team of scar changes |
| Patient with ovarian cancer and a dysfunctional keloid scar for which no one had recommended treatment | Addresses the scar and provides education on scar care: an example of why referrals should be systematic, including for other cancers |
| Patient with neuropathy in her feet who falls on public transportation and fractures her scaphoid because she cannot feel her feet | Fall prevention: footwear, visual compensation, safety strategies for getting around, and subsequent functional recovery of the hand |
| “I feel like I’ve gotten stupid”: memory lapses lead to family arguments and guilt over things she cannot remember doing | Psychoeducation for the patient and family, shared compensatory strategies (planner, logs), and referral to psycho-oncology if there is distress |
| Highly active attorney who feels that her routine has fallen apart after treatment: “I get up and have no purpose” | Rebuilding a routine with graded meaningful activities, goals agreed on using the COPM, and preparation for returning to work |
What the evidence says about occupational therapy for breast cancer
Evidence for OT intervention in oncology is growing, particularly for addressing cognitive effects:
- Our systematic review, published in the American Journal of Occupational Therapy, analyzed the effect of occupational therapy, with or without transcranial direct current stimulation (tDCS), in women with breast cancer and chemobrain. OT interventions showed a positive trend in occupational performance, cognition (memory and attention), and quality of life; tDCS showed promise but remains understudied (Castelao-Alburquerque et al., 2026).
- More broadly, cognitive rehabilitation improves objective and subjective cognition in cancer survivors, whether it involves training, compensatory strategies, or a combination of the two (Nakamura et al., 2024).
Limitations
These findings should be interpreted with caution. Estimates of cognitive impairment prevalence vary depending on the measurement method, and the certainty of the evidence is very low (Whittaker et al., 2022). In addition, the effect of cognitive rehabilitation on everyday functioning is still unclear (Nakamura et al., 2024). More studies are needed that measure occupational outcomes, not just cognitive or physical ones.
Conclusion
Increasing breast cancer survivorship means we need to look beyond a cure. Lymphedema, neuropathy, fatigue, and cognitive impairment are common effects that, together, affect many women’s self-care, work, and roles.
Occupational therapy brings an occupation-centered perspective to the breast cancer unit: it supports patients from diagnosis through survivorship, prevents and identifies effects early, and intervenes so they can regain what matters to them. Including OT in oncology teams is one way to make care truly comprehensive.
Because the goal is not just to live after cancer, but to live well.
Additional information from NeuronUP
Remote metacognitive strategy training after breast cancer: a 2026 trial
A pilot randomized trial published in July 2026 in Archives of Physical Medicine and Rehabilitation delivered the CO-OP approach (Cognitive Orientation to daily Occupational Performance) by videoconference. This metacognitive strategy training was provided to 42 breast cancer survivors with cognitive complaints after chemotherapy. The CO-OP group received 10 weekly 45-minute sessions and was compared with an attention-and-education control group.
Retention was 91.3%, and participants rated the remote format as highly feasible and acceptable. The CO-OP group showed small to moderate effects on activity performance goals, cognition in everyday life, and measures of executive function. Because this was a small pilot study, the findings are preliminary and need to be confirmed in efficacy trials.
Source: Boone, A., Kiselica, A., Earwood, J., Golzy, M., Reid-Arndt, S., y Wolf, T. J. (2026). Feasibility testing of remotely delivered metacognitive strategy training in cancer-related cognitive impairment. Archives of Physical Medicine and Rehabilitation, 107(7), 1629–1637. https://doi.org/10.1016/j.apmr.2025.11.027
References
- Argyriou, A. A., Karteri, S., Bruna, J., Mariotto, S., Simo, M., Velissaris, D., Kalofonou, F., Cavaletti, G., Ferrari, S., y Kalofonos, H. P. (2022). Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: A prospective study. Supportive Care in Cancer, 30(2), 1807–1814. https://doi.org/10.1007/s00520-021-06509-x
- Castelao-Alburquerque, E., Huertas-Hoyas, E., García-Bravo, C., Poveda-García, A., Fernández-Gómez, G., Donovan, M., Pérez-Corrales, J., y Rodríguez-Pérez, M. P. (2026). Occupational therapy intervention to mitigate chemotherapy-induced cognitive impairment among breast cancer patients: A systematic review. American Journal of Occupational Therapy, 80(2), 255–264. https://doi.org/10.5014/ajot.2026.051347
- Chiaravalloti, A., Filippi, L., Pagani, M., y Schillaci, O. (2023). Functional imaging of chemobrain: Usefulness of nuclear medicine in the fog coming after cancer. Journal of Nuclear Medicine, 64(4), 508–514. https://doi.org/10.2967/jnumed.121.263294
- DiSipio, T., Rye, S., Newman, B., y Hayes, S. (2013). Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. The Lancet Oncology, 14(6), 500–515. https://doi.org/10.1016/S1470-2045(13)70076-7
- Janelsins, M. C., Kesler, S. R., Ahles, T. A., y Morrow, G. R. (2014). Prevalence, mechanisms, and management of cancer-related cognitive impairment. International Review of Psychiatry, 26(1), 102–113. https://doi.org/10.3109/09540261.2013.864260
- Nakamura, Z. M., Ali, N. T., Crouch, A., Dhillon, H., Federico, A., Gates, P., Grech, L., Kesler, S. R., Ledbetter, L., Mantovani, E., Mayo, S., Ng, D. Q., Pembroke, L., Pike, K. E., Tamburin, S., Tan, C. J., Toh, Y. L., Yang, Y., Von Ah, D., y Allen, D. H. (2024). Impact of cognitive rehabilitation on cognitive and functional outcomes in adult cancer survivors: A systematic review. Seminars in Oncology Nursing, 40(5), 151696. https://doi.org/10.1016/j.soncn.2024.151696
- Newman, R. M., Polo, K. M., Amanat, Y., Campbell, C., Fleischer, A., y Morikawa, S. (2024). Occupational therapy practice guidelines for adults living with and beyond cancer. American Journal of Occupational Therapy, 78(5), 7805397010. https://doi.org/10.5014/ajot.2024.078501
- Schmidt, M. E., Scherer, S., Wiskemann, J., y Steindorf, K. (2019). Return to work after breast cancer: The role of treatment-related side effects and potential impact on quality of life. European Journal of Cancer Care, 28(4), e13051. https://doi.org/10.1111/ecc.13051
- Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L. A., y Fallon, M. (2014). Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain, 155(12), 2461–2470. https://doi.org/10.1016/j.pain.2014.09.020
- Sociedad Española de Oncología Médica [SEOM] y Red Española de Registros de Cáncer [REDECAN]. (2026). Las cifras del cáncer en España 2026. SEOM.
- Whittaker, A. L., George, R. P., y O’Malley, L. (2022). Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: A systematic review and meta-analysis. Scientific Reports, 12(1), 2135. https://doi.org/10.1038/s41598-022-05682-1
- Zajączkowska, R., Kocot-Kępska, M., Leppert, W., Wrzosek, A., Mika, J., y Wordliczek, J. (2019). Mechanisms of chemotherapy-induced peripheral neuropathy. International Journal of Molecular Sciences, 20(6), 1451. https://doi.org/10.3390/ijms20061451
Frequently asked questions about occupational therapy for breast cancer
1. What does occupational therapy do for breast cancer?
It evaluates what the woman can no longer do because of cancer and treatment effects, and what she needs to regain those abilities. In collaboration with the rest of the breast cancer unit team, it addresses self-care, household tasks, work, caring for others, and leisure, from diagnosis through survivorship.
2. What effects of breast cancer does occupational therapy address?
The most common include scar changes and fitting an external prosthesis, lymphedema and limited shoulder mobility, peripheral neuropathy, cancer-related fatigue, cancer-related cognitive impairment (chemobrain), and emotional impact. These effects rarely occur in isolation: it is their combined impact that affects occupational performance.
3. How is chemobrain identified?
The patient’s own perception, measured using questionnaires such as the FACT-Cog, is combined with neuropsychological and screening tests, although there is no consensus on which are best. Markers such as functional neuroimaging or neurofilament light chain are still research tools, so functional assessment remains essential.
4. When should occupational therapy begin for breast cancer?
Ideally, it should be part of care from diagnosis—not just after treatment effects have become established—in order to prevent, identify concerns early, and provide support. With a referral protocol, patients can be referred to occupational therapy when fatigue, tingling, scar discomfort, memory problems, or questions about returning to work arise, or before surgery.
5. What is the relationship between occupational therapy for breast cancer, cognitive rehabilitation, and NeuronUP?
After treatment, cognitive rehabilitation is part of occupational therapy intervention: psychoeducation, compensatory strategies, and cognitive training linked to real-life goals. Platforms such as NeuronUP offer cognitive stimulation activities that professionals can tailor to each patient’s goals. Evidence shows that cognitive rehabilitation improves cognition, although its effect on everyday functioning is still unclear.







Wearables and Artificial Intelligence in Neurorehabilitation: SensorFM’s Clinical Potential
Leave a Reply